New York State Common Retirement Fund’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.04M | Buy |
79,030
+52,813
| +201% | +$2.03M | ﹤0.01% | 1261 |
|
2025
Q1 | $1.02M | Buy |
26,217
+22,965
| +706% | +$890K | ﹤0.01% | 1621 |
|
2024
Q4 | $110K | Sell |
3,252
-133,513
| -98% | -$4.52M | ﹤0.01% | 2554 |
|
2024
Q3 | $5.59M | Buy |
136,765
+130,137
| +1,963% | +$5.32M | 0.01% | 1046 |
|
2024
Q2 | $255K | Sell |
6,628
-95,404
| -94% | -$3.67M | ﹤0.01% | 2326 |
|
2024
Q1 | $4.37M | Buy |
102,032
+95,404
| +1,439% | +$4.09M | 0.01% | 1170 |
|
2023
Q4 | $246K | Hold |
6,628
| – | – | ﹤0.01% | 2373 |
|
2023
Q3 | $240K | Sell |
6,628
-204,965
| -97% | -$7.42M | ﹤0.01% | 2347 |
|
2023
Q2 | $7.54M | Sell |
211,593
-80,494
| -28% | -$2.87M | 0.01% | 1000 |
|
2023
Q1 | $10.4M | Sell |
292,087
-13,544
| -4% | -$482K | 0.01% | 856 |
|
2022
Q4 | $10.7M | Sell |
305,631
-112,735
| -27% | -$3.96M | 0.01% | 838 |
|
2022
Q3 | $12.3M | Buy |
418,366
+136,432
| +48% | +$4.02M | 0.02% | 747 |
|
2022
Q2 | $15.3M | Sell |
281,934
-6,176
| -2% | -$336K | 0.02% | 671 |
|
2022
Q1 | $15.7M | Buy |
288,110
+279,742
| +3,343% | +$15.2M | 0.02% | 759 |
|
2021
Q4 | $461K | Buy |
8,368
+1,963
| +31% | +$108K | ﹤0.01% | 2474 |
|
2021
Q3 | $306K | Buy |
+6,405
| New | +$306K | ﹤0.01% | 2713 |
|
2021
Q1 | – | Sell |
-132,604
| Closed | -$6.1M | – | 3296 |
|
2020
Q4 | $6.1M | Sell |
132,604
-108,226
| -45% | -$4.98M | 0.01% | 1179 |
|
2020
Q3 | $11.3M | Buy |
240,830
+28,080
| +13% | +$1.32M | 0.01% | 793 |
|
2020
Q2 | $10.8M | Sell |
212,750
-76,361
| -26% | -$3.89M | 0.01% | 834 |
|
2020
Q1 | $13.7M | Buy |
289,111
+206,181
| +249% | +$9.77M | 0.02% | 655 |
|
2019
Q4 | $4.87M | Buy |
82,930
+2,664
| +3% | +$156K | 0.01% | 1262 |
|
2019
Q3 | $4.28M | Hold |
80,266
| – | – | 0.01% | 1301 |
|
2019
Q2 | $4.02M | Buy |
+80,266
| New | +$4.02M | 0.01% | 1345 |
|